ストックスクリーナーアプリを入手
28.89
4.16%
1.155
プレマーケット:
28.89
-0.005
-0.02%
前日終値:
$27.74
開ける：
$27.74
24時間の取引高:
179.40K
Relative Volume:
0.96
時価総額：
$572.62M
収益：
$71.10M
当期純損益:
$-6.38M
株価収益率:
-24.06
EPS:
-1.2009
ネットキャッシュフロー:
$-39.84M
1週間 パフォーマンス:
+7.18%
1か月 パフォーマンス:
+26.18%
6か月 パフォーマンス:
-5.51%
1年 パフォーマンス:
+59.29%
1日の値動き範囲:
$27.20
$29.00
1週間の範囲:
$26.06
$29.00
52週間の値動き範囲:
$16.90
$39.70
Assembly Biosciences Inc Stock (ASMB) Company Profile
名前
Assembly Biosciences Inc
セクター
電話
(833) 409-4583
住所
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Compare ASMB vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
28.89 | 544.58M | 71.10M | -6.38M | -39.84M | -1.2009 |
VRTX
Vertex Pharmaceuticals Inc
|
529.59 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
649.81 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
916.80 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.99 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-24 | 開始されました | Citizens JMP | Mkt Outperform |
| 2025-08-18 | 再開されました | H.C. Wainwright | Buy |
| 2025-03-25 | 開始されました | Guggenheim | Buy |
| 2024-09-20 | アップグレード | Jefferies | Hold → Buy |
| 2021-09-13 | 開始されました | H.C. Wainwright | Neutral |
| 2021-09-02 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | ダウングレード | Jefferies | Buy → Hold |
| 2020-10-19 | 開始されました | Truist | Buy |
| 2019-10-16 | 開始されました | Mizuho | Buy |
| 2018-11-19 | 開始されました | Leerink Partners | Outperform |
| 2018-10-08 | アップグレード | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | 開始されました | Robert W. Baird | Outperform |
| 2018-04-13 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | 開始されました | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | 開始されました | Jefferies | Buy |
| 2017-05-30 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Assembly Biosciences Inc (ASMB) 最新ニュース
Discipline and Rules-Based Execution in ASMB Response - Stock Traders Daily
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 2000 Index - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 2000 Value Benchmark - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 3000E Index - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS:ASMB) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 3000E Value Benchmark - marketscreener.com
Health Care had the best week vs. the S&P 500 on record (XLV:NYSEARCA) - Seeking Alpha
Assembly Biosciences, Inc. Actuals & Estimates (NASDAQ:ASMB) - TradingView
Assembly Biosciences, Inc. Actuals & Estimates (TRADEGATE:V7B) - TradingView
ASMB Forecast — Price Target — Prediction for 2027 - TradingView
Assembly Biosciences Inc (ASMB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Assembly Biosciences Inc (ASMB) Institutional Confidence - TradingKey
Behavioral Patterns of ASMB and Institutional Flows - Stock Traders Daily
Assembly Biosciences (ASMB) PFO sells 29 shares to cover RSU taxes - Stock Titan
Assembly Biosciences Inc (ASMB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Assembly Biosciences Inc (ASMB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Assembly Biosciences Inc (ASMB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Assembly Biosciences Inc (ASMB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Assembly Biosciences Inc (ASMB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Assembly Biosciences Inc (ASMB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Assembly Biosciences Inc (ASMB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ASMB Maintained by Mizuho -- Price Target Raised to $45 - GuruFocus
Mizuho Raises Price Target on Assembly Biosciences to $45 From $40, Keeps Outperform Rating - Moomoo
Assembly Biosciences eyes Gilead HSV plan as ABI-6250 liver pipeline expands - MSN
ASMB SEC FilingsAssembly Bioscie 10-K, 10-Q, 8-K Forms - Stock Titan
Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead - MarketBeat
(ASMB) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Assembly Biosciences Expands Equity Plans, Reelects Board - TipRanks
Assembly Biosciences (ASMB) CMO awarded 14,000-share RSU-based stock grant - Stock Titan
Assembly Biosciences (ASMB) CMO awarded 14,000 restricted stock units - Stock Titan
Assembly Biosciences (NASDAQ: ASMB) awards 8,000 stock options to director McHutchison - Stock Titan
Assembly Biosciences (ASMB) director receives grant of 8,000 stock options - Stock Titan
Director at Assembly Biosciences (ASMB) receives grant of 8,000 stock options - Stock Titan
Assembly Biosciences (NASDAQ: ASMB) director receives 8,000 stock options grant - Stock Titan
Assembly Biosciences (NASDAQ: ASMB) director receives grant of 8,000 stock options - Stock Titan
Director at Assembly Biosciences (NASDAQ: ASMB) receives 8,000 options - Stock Titan
Assembly Biosciences (NASDAQ: ASMB) PFO awarded 3,500 RSUs - Stock Titan
Assembly Biosciences (ASMB) CSO granted 14,000 RSUs tied to plan amendment - Stock Titan
Assembly Biosciences (ASMB) CEO receives 50,750 RSUs in equity grant - Stock Titan
Assembly Biosciences (ASMB) shareholders back directors, equity plan and ESPP share hikes - Stock Titan
Assembly Biosciences Eyes Gilead HSV Plan as ABI-6250 Liver Pipeline Expands - Yahoo Finance
Assembly Biosciences synthesizes new anti-cytomegalovirus agents - BioWorld News
Gilead Sciences, Inc. Acquires Significant Stake in Assembly Biosciences Inc. - GuruFocus
Assembly Biosciences Announces Upcoming Investor Conference Presentations - The Manila Times
ASMB Reiterated by Guggenheim -- Price Target Maintained at $43 - GuruFocus
Biotech Assembly Bio set for June Jefferies, Goldman investor chats - Stock Titan
Assembly Biosciences (ASMB) Holds Steady Near Resistance as Biotech Sector WatchesSector ETF Flow - The Legal Advocate
How (ASMB) Movements Inform Risk Allocation Models - Stock Traders Daily
Gilead boosts Assembly Biosciences (NASDAQ: ASMB) ownership to 25.1% of shares - Stock Titan
Gilead adds Assembly Biosciences (ASMB) shares through new stock grant - Stock Titan
Assembly Biosciences (ASMB) Declines 4.7% as Stock Tests Key Support Near $26PCR Moving Average - newsline.com
Assembly Biosciences Inc (ASMB) 財務データ
収益
当期純利益
現金流量
EPS
Assembly Biosciences Inc (ASMB) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Bjorkquist Jeanette M | PFO and PAO |
Mar 30 '26 |
Sale |
26.69 |
328 |
8,755 |
11,089 |
| White Nicole S | Chief Manufacturing Officer |
Mar 30 '26 |
Sale |
26.69 |
197 |
5,258 |
37,477 |
0.05%
0.74%
大文字化:
|
ボリューム (24 時間):